The Pharma Letter17h
New data for amlitelimab published in JACI
New research has been published in the Journal of Allergy and Clinical Immunology (JACI) that shows treatment with ...
The Pharma Letter17h
Alteogen jumps as it inks licence deal with Daiichi Sankyo
South Korea’s Alteogen (Kosdaq: 196170) has signed an exclusive licensing agreement with Japanese pharmaceutical company ...
The Pharma Letter21h
US FDA to consider Dizal’s first-in-class lung cancer drug
Dizal has submitted an application to the US FDA for sunvozertinib, an oral EGFR inhibitor for advanced NSCLC with EGFR exon 20 insertion mutations, aimed at patients after platinum-based chemotherapy ...
The Pharma Letter17h
Axon Pharma
"A dynamic and versatile pharmaceutical company with regional horizons in Latin America." "Axon Pharma is an independent multinational pharmaceutical company built on high-standards science and ...